Journal of Tumor Research: Chemotherapy for Stage II Classical Hodgkin Lymphoma


Journal of Tumor Research: Chemotherapy for Stage II Classical Hodgkin Lymphoma

Journal of Tumor Research is an open access journal which covers different areas of all the tumors and cancer including breast cancer, prostrate, Lung cancer, ovarian cancer, malignant tumor cells, brain tissue, neurofibromatosis, multiple endocrine neoplasia, meningioma, neuroblastoma, astrocytoma and brain neoplasm. The most common type of tumors are glioblastoma and glioma. A metastatic tumours are the cancer cells that develop in a body organ such as the lung can spread via direct extension, or through the bloodstream to other body organs such as the brain. Other types of tumors include skull metastasis, meningeal carcinomatosis, medulloblastoma and central neurocytoma.

The journal is using Editorial Tracking System for online manuscript submission, review and tracking. Editorial board members of the journal and others who are expertise will review the manuscripts. At least two independent reviewer’s approval followed by acceptance from the editor of the manuscript is required.

Chemotherapy for Stage II Classical Hodgkin Lymphoma

Plasmablastic lymphoma (PBL) is a rare malignancy derived from activated B cells within the germinal center in the process of transformation to plasma cells. The neoplasm is an aggressive and diagnostically challenging type of lymphoma. It is most commonly associated with HIV infection, but may also occur in other immunodeficiencies, elderly patients, and immunocompetent individuals. In this paper, we discuss the clinic pathologic features of a 93- year-old male, possibly the oldest reported case, with PBL, status post-chemotherapy for Hodgkin lymphoma, initially suspected of representing reactive, possibly infectious, lymphadenopathy versus recurrent Hodgkin lymphoma.

On his current presentation, the patient’s hemoglobin was 6.2 mg/dL, prompting transfusions with two units of packed red blood cells. He had a recent bone marrow biopsy which showed no evidence of malignancy with normal floZ cytometry as well as cytogenetics. Since the diagnosis of Hodgkin lymphoma, the patient had multiple CT scans. A recent PET CT showed extensive hyper metabolic activity which, however, was fairly stable from the prior PET scan done two months earlier. Given the persistent, but not increasing, activity the findLnJs were clinically suspicious for possibly chronic Lnflammator\ condition or infectious etiology rather than lymphoma, which would generally increase in size. An inguinal lymph node biopsy was recommended for pathological diagnosis.

Best Regards:
Mary Wilson
Journal Manager

Journal of Tumor Research